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Introduction: Regression modeling is a statistical method commonly used in health research, especially 
by observational studies.
Objective: The objectives of this paper were to 1) determine the frequency of reporting of regression 
modeling in original biomedical and public health articles that were published in Biomédica between 
2000 and 2017; 2) describe the parameters used in the statistical models, and 3) describe the quality 
of the information reported by the studies to explain the statistical analyses.
Materials and methods: We conducted a critical assessment review of all original articles published 
in Biomédica between 2000 and 2017 that used regression models for the statistical analysis of the 
studies main objectives. We generated a 20-item checklist based on four good practice guidelines for 
the presentation of statistical methods. 
Results: Most of the studies were observational studies related to public health sciences (65.7%). 
Less than half (37.2%) of them reported using a combination of conceptual frameworks and statistical 
criteria for the selection of variables to be included in the regression model. Less than one quarter 
(22.1%) reported the verification of the assumptions of the model. The most frequently used uncertainty 
measure was the p-value (73.5%).
Conclusion: There are significant limitations in the quality of the reports of statistical regression models, 
which reviewers and readers need in order to correctly assess and interpret the statistical models. The 
results, herein, are provided as an invitation to researchers, reviewers, and editors of biomedical journals 
to develop, promote, and control an appropriate culture for statistical analysis and reporting in Colombia.
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Reporte estadístico en los análisis de regresión en Biomédica: una revisión y evaluación crítica 
Introducción. Los modelos de regresión son métodos estadísticos comúnmente utilizados en la 
investigación en salud, especialmente en estudios observacionales.
Objetivos. Determinar la frecuencia de uso de modelos de regresión en los artículos originales de 
biomedicina y salud pública publicados en Biomédica entre 2000 y 2017, describir los parámetros 
utilizados en los modelos estadísticos, así como la calidad de la información reportada por los estudios 
para explicar el análisis estadístico.
Materiales y métodos. Se hizo una revisión y evaluación crítica de todos los artículos originales 
publicados en la revista Biomédica entre 2000 y 2017 que utilizaron modelos de regresión en el análisis 
estadístico. Se construyó una lista de verificación de 20 ítems sobre la base de cuatro guías de buenas 
prácticas para la presentación de los métodos estadísticos.
Resultados. La mayoría de los estudios incluidos eran estudios observacionales relacionados con 
las ciencias de la salud pública (65,7 %). En menos de la mitad (37,2 %) de ellos se informó sobre 
el uso de una combinación de marco conceptual y criterios estadísticos para la selección de las 
variables incluidas en el modelo de regresión; en menos de una cuarta parte (22,1 %) se informó de la 
verificación de los supuestos del modelo, y la medida de incertidumbre reportada con mayor frecuencia 
fue el valor de p (73,5 %).
Conclusión. Hay limitaciones importantes en la calidad de los informes de los modelos de regresión 
estadísticos necesarios para la correcta evaluación y la interpretación de los modelos estadísticos 
por parte de los revisores y lectores. Los resultados se ofrecen como una invitación a investigadores, 
revisores y editores de revistas biomédicas a que promuevan el desarrollo de una cultura adecuada de 
análisis estadístico y presentación de informes en Colombia.
Palabras clave: bioestadística; análisis de datos; análisis de regresión; sesgo (epidemiología); Colombia.
doi: https://doi.org/10.7705/biomedica.v38i0.3648
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Evidence-based medicine and public health cur-
rently serve as the predominant paradigms in the 
provision of health services (1). Primary, secondary, 
and tertiary prevention interventions for specific 
diseases are largely based on clinical guidelines, 
while public health interventions to address health 
problems at a population level are largely based 
on proven successful programs (2). Both clinical 
guidelines and public health programs rely mostly 
on quantitative research that provides evidence of 
the efficacy, effectiveness, and efficiency of inter-
ventions, and indicate the strength of associations 
between risk factors and health outcomes. Contrary 
to the principles of evidence-based medicine, 
the quality of the evidence presented by health 
research is usually assessed exclusively according 
to the type of study design (3). This widely used 
approach assumes that the statistical methods 
related to a specific study design are unbiased and 
free of random error and misspecification.
Regression modeling is a statistical method com-
monly used in health research, and especially for 
observational studies. The selection of the type 
of regression model, the selection and inclusion 
of model variables, and the assessment of model 
diagnostics are some of the key actions that should 
be specified and properly conducted in order to 
obtain valid statistical results (4). The absence 
or misuse of an appropriate regression modeling 
technique could lead to erroneous results and 
conclusions, and while regression modeling plays 
a central role in quantitative health research, little 
attention has been given to the appropriateness 
of the statistical methods used by epidemio-
logical studies to reach results and conclusions 
(5). In Colombia, the national bibliographic index 
Publindex has ranked Biomédica as a top journal 
in the health sciences field (6), and, therefore, a 
large amount of original health research performed 
in the country and the region has been published 
in this journal.
The objectives of this paper were to 1) determine 
the frequency with which regression modeling was 
reported in original biomedical and public health 
articles published in Biomédica between 2000 and 
2017 (including online ahead of print); 2) describe 
the reporting of the parameters and procedures 
used for the statistical models, and 3) describe the 
quality of the information reported by the studies 
to explain and evaluate the statistical analyses. 
We also aimed at providing an overview of the 
statistical quality of regression modeling reported 
in the health literature published in Biomédica and 
based on those reports, identify the strengths and 
limitations of the statistical methods.
Materials and methods
We reviewed all original articles published in 
Biomédica between 2000 and 2017 (including 
online ahead of print publications in the 2016 and 
2017 issues), which are available at the official 
Biomédica’s website (www.revistabiomedica.org). 
We then selected the articles that reported the use of 
at least one statistical regression model, according 
to the following selection criteria: 1) original articles 
that used one or more regression analyses; 2) 
regression analyses that were conducted in order 
to address the study’s main objective, and 3) 
regression analyses that were presented in the 
methods and results sections. When an original 
study included two or more regression analyses, 
we selected the regression model that was related 
to the study’s main objective. When a study had 
two or more main objectives, we selected one 
model per objective. Therefore, we included more 
than one regression model per original article when 
they corresponded to different main objectives and 
specifications. 
We conducted a literature review to identify papers 
that assessed the quality of statistical reporting in 
biomedical journals and found four publications 
that presented good practice guidelines for the 
presentation of statistical methods (5,7-9). The 
first publication appeared in 1992 when the Inter-
national Committee of Medical Journal Editors 
(ICMJE) issued a set of publication requirements 
for biomedical journals. Then, in order to better 
address the needs of readers the ICMJE proposed 
the first standards for the presentation of statistical 
information, aimed at supporting and informing 
authors and editors about the statistical principles 
behind the studies published in biomedical journals 
(7). The second article was published in 2013 and 
its purpose was to develop a checklist to determine 
the frequency of the use of regression models in 
economics, and the parameters and the amount 
of information reported. That checklist grouped 
items according to four consecutive stages of the 
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statistical process (8). Later, the proposal titled 
“Strategies for the Development of Statistical 
Regression Models” described important points to 
consider when using a regression model, such as 
data manipulation, modeling strategies, final model 
evaluation, and presentation (9). Lastly, Lang and 
Altman recently published a general guideline for 
reporting methods and statistical analyses in bio-
medical journals, which included 12 items specific 
to regression analyses (5). 
Some of the important items in one or two of the 
checklists mentioned were missing from the others, 
and none of the lists was comprehensive enough to 
assess the quality of the presentations of the sta-
tistical regression models. Therefore, we consoli-
dated all of the items in the four publications relevant 
for the evaluation of regression modeling into one 
checklist containing 20 statistical procedures or 
parameters. These were evaluated based on the 
four different stages proposed by Kearns, et al. 
(8): I) pre-statistical modeling considerations; II) 
specification of the final model; III) presentation of 
the final model; and IV) validation of the final model. 
In general, the guidelines on good practices for 
statistical reporting (5,7,8), and the checklist 
based on these guidelines used for this critical 
assessment, can be summarized by the following 
standards: 1) agreement of the statistical method 
with the measurement scale and data structure 
of the study variables; 2) coherence between 
the statistical method and the study objective; 3) 
verification of the statistical model’s assumptions 
and understanding of the theoretical basis of the 
statistical tests used; 4) assessment of the diag-
nostics and goodness of fit of the final model 
according to the regression method used; 5) 
evaluation of the final model and comparing it 
to alternative models, and 6) discussion of the 
strengths and limitations of the final model.
The checklist used for this work was reviewed by 
two experts in statistical analyses, and then adapted 
based on their recommendations. Appendix 1 pres-
ents the full checklist and Appendix 2 compares 
the four checklists with the items included in the 
one used for this review. It is important to mention 
that we did not evaluate or validate the regression 
models themselves but only the reporting, according 
to each stage of the process.
Two independent reviewers with statistical and bio-
medical experience performed a critical assess-
ment of the 20 items included in the checklist. The 
reviewers were blinded to the authorship of the 
original articles. In addition, a third reviewer was 
assigned to assess three articles that were written 
by the other reviewers.
Most of the checklist items were dichotomized as 
“yes/no” responses and accompanying observa-
tions and explanations about the selections were 
included. A third reviewer resolved disagreements. 
We used the Cohen’s kappa statistic to assess 
agreement among the independent reviewers’ 
responses and we calculated a pooled (inter-
rater) kappa for multiple items since the checklist 
contained several items. We present a descrip-
tive analysis of the results using frequencies 
and grouped by six-year periods. We conducted 
the statistical analyses using Stata 12™ (Stata 
Corporation, College Station, TX, USA).
Results
We reviewed 755 original articles published in 
Biomédica during the study period. Regression 
analyses were used in 163 articles (21.6%) and 
after exclusions, 108 original studies and 113 
regression models were included in the review 
(figure 1). Appendix 3 presents a full list of the 
articles included. The review process had an inter-
rater agreement of 0.94. 
Most of the studies were related to public health 
sciences (65.7%) and the remaining ones to bio-












Exclusions n = 55
No main objective: 44
No methods or results
description: 11
Figure 1. Flow diagram of the process to select the studies 
included in this review
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sectional studies were the most frequent (38.9%), 
followed by cohort studies (23.2%). Table 1 pres-
ents the characteristics of the studies.
With regard to stage I, “pre-statistical modeling 
considerations”, 37.2% of the models reported 
using a combination of conceptual frameworks 
and statistical criteria to select the variables to be 
included in the regression models. With regard 
to the models that used statistical procedures or 
a combination of conceptual frameworks and sta-
tistical criteria to select the variables (n=49), the 
stepwise strategy was the most frequently (50%) 
reported. The logistic regression model was the 
most frequent type of model (56.6%), followed 
by the linear regression model (25.7%). A small 
proportion of studies (8.9%) mentioned “missing 
data” in their reporting of data quality. Table 2 
presents the reporting of the statistical information 
related to the regression models according to 
checklist stages, items, and six-year periods.
With respect to stage II, “specification of the final 
model”, 22.1% of the models reported the veri-
fication of the assumptions of the model with 
normality and linearity being the most and least 
frequent assumptions verified (65.0% and 12.0%, 
respectively). Model comparisons (9.7%) and model 
equations (8.0%) were the least frequent items 
reported by the studies.
With regard to stage III, “presentation of the final 
model”, 90.3% of the studies reported regression 
coefficients and the uncertainty measure reported 
with the highest frequency was the p value (73.5%), 
which increased over the six-year periods. 
For stage IV, “validation of the final model”, 46% 
of the studies reported the goodness of fit of the 
model and 1.7% reported on tests for model per-
formance. Regression models were discussed only 
in 15.9% of the articles.
In terms of the frequency of reporting by six-year 
periods, a decreasing pattern was found in the 
reporting of the following checklist items: Sufficient 
explanations for all variables used in the analysis; 
alpha parameter for variable inclusion, missing 
data; bias assessment for data quality; verification 
of the model’s assumptions, and goodness of fit 
measures. The discussion on the statistical models 
presented in the studies also decreased over time. 
In contrast, there was an increase in reporting on 
the combined use of conceptual frameworks and 
statistical criteria for the inclusion of variables in 
models of association.
Discussion
We conducted a critical assessment review of 
original studies that used statistical regression 
models and were published in Biomédica between 
2000 and 2017. The results show significant weak-
nesses in the reporting of the statistical information 
or parameters needed by reviewers and readers 
in order to correctly assess and interpret statis-
tical models. While the number of studies that 
use regression models has increased since 2000, 
the descriptive analysis which we performed by 
six-year periods showed that rather than having 
improved, the reporting of statistical information 
has worsened over time for a large number of key 
items in the checklist.
Table 1. Characteristics of the included original studies that used regression models by six-year periods, Biomédica, 2000-2017
General characteristics of 
studies
Six-year periods
2000/2005 2006/2011 2012/2017* All
n=15 % n=38 % n= 55 % N=108 %
Area of study
Public health 13 86.7 23 60.6 35 63.6 71 65.7
Biomedicine and others 2 13.3 15 39.4 20 36.4 37 34.3
Study design
Clinical trial 0 0 2   5.3 1 1.8 3 2.8
Cohort study 2 13.3 9 23.7 14 25.5 25 23.2
Case and control study 2 13.3 4 10.5 9 16.4 15 13.9
Cross-sectional study 9 60 10 26.3 23 41.8 42 38.9
Ecologic study 0 0 1   2.6 3 5.4 4 3.7
Basic research study 0 0 7 18.4 1 1.8 8 7.4
Economic analysis 0 0 2   5.3 0 0.0 2 1.9
Quasi-experimental 1   6.7 3   7.9 0 0.0 4 3.7
Others** 1   6.7 0   0.0 4 7.3 5 4.6
*Including online ahead-of-print publications for 2016 and 2017 issues
** Analysis of secondary and/or administrative sources without a specified design (more than two sources or information systems)
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Table 2. Information about regression models as reported by the original studies by six-year periods, Biomédica, 2000-2017
Stages/Items
Six-year periods
2000-2005 2006-2011 2012-2017* All
n=20 % n=38 % n=55 % N**=113 %
Stage I “Pre-statistical modeling considerations”
1. Objectives of the analysis 12 60 32 84.2 43 78.2   87 77.0
2. Type of analysis
Linear regression 7 35 12 31.6 10 18.2   29 25.7
Logistic regression 12 60 19 50.0 33 60.0   64 56.6
Poisson regression 0   0   1   2.6   6 10.9     7   6.2
Negative binomial regression 0   0   2   5.3   1   1.8     3   2.7
Cox regression 1   5   2   5.3   2   3.6     5   4.4
Log-binomial regression 0   0   1   2.6   1   1.8     2   1.8
Other 0   0.0   1   2.6   2   3.6     3   2.7
3. Sample size of the final model 9 45 11 29   9 16.4   29 25.7
4. Sufficient explanations for all variables used in the analysis 15 75.0 29 76.3 38 69.1   82 72.6
5. Scale of the response variable
Continuous 4 20.0 11 29.0 12 21.8   27 23.9
Count 1   5.0   3   7.9   3   5.5     7   6.2
Binary 10 50.0 11 29.0 28 50.9   49 43.4
Polynomial ordinal 0   0.0   0   0.0   1   1.8     1   0.9
Logarithmic 0   0.0   4 10.5   1   1.8     5   4.4
Unclear 5 25.0   9 23.7 10 18.2   24 21.2
6. Transformation of variables 7 35.0 14 36.8 17 30.9   38 33.6
7. Selection process for including variables in the regression analysis         
Literature or conceptual framework 11 55.0 22 57.9 26 47.3   59 52.2
7.1.1 Statistical (bivariate and/or stepwise) 5 25.0   0   0.0   2   3.6     7   6.2
Literature/conceptual framework and statistical 3 15.0 13 34.2 26 47.3   42 37.2
Not specified 1   5.0   3   7.9   1   1.8     5   4.4
7.1.2 Alpha for inclusion of variables 6 75.0   8 50.0 14 48.3   28 52.8
8. Quality of data
Reporting of missing data 5 25.0   2   5.3   3   5.5   10   8.9
Reporting of outliers 0   0.0   3   7.9   2   3.6     5   4.4
Bias reporting 10 50.0 11 29.0   9 16.4   30 26.6
9. Statistical package or program used for the analysis
SPSS 10 50.0 13 34.2 17 30.9   40 35.4
STATA 4 20.0   8 21.1 21 38.2   33 29.2
Epi Info 3 15.0   2   5.3   0   0.0     5   4.4
R package 0   0.0   0   0.0   5   9.1     5   4.4
Other 0   0.0   8 21.1   7 12.7   15 13.3
Not specified 3 15.0   7 18.4   5   9.1   15 13.3
Stage II “Specification of the final model”
10. Analysis assumptions 7 35.0 12 31.6   6 10.9   25 22.1
10.1 Independence 5 20.0   3 12.0   1   4.0     9 36.0
10.1 Normality 2   8.0   9 36.0   3 12.0   14 56.0
10.1 Homocedasticity 2   8.0   4 16.0   3 12.0     9 36.0
10.1 Linearity 2   8.0   1   4.0   0   0.0     3 12.0
11. Collinearity 2 10.0   7 18.4   8 14.6   17 15.0
12. Strategy for the verification of assumptions 3 42.9   4 33.3   3 50.0   10 40.0
13. Comparison of models
Yes, but no mention of strategy 1   5   7 18.4   3   5.5   11   9.7
Yes and strategy mentioned 2 10   1   2.6   3   5.5     6   5.3
14. Report of the model equation 0   0   6 15.8   3   5.5     9   8.0
Stage III. “Presentation of the final model”
15. Graphs or tables that communicate the results
Graphics 1 25.0   4 40.0   5 38.5   10 37.0
Tables 16 84.2 29 82.9 44 84.6   89 84.0
16. Measures of association and uncertainty
Coefficient 18 90.0 33 86.8 51 92.7 102 90.3
p values 14 70.0 28 73.7 41 74.6   83 73.5
Confidence intervals (CI) 14 70.0 25 65.8 38 69.1   77 68.1
Standard error 6 30.0   2   5.3   7 12.7   15 13.3
Stage IV “Validation of the final model”
17. Goodness of fit 12 60.0 16 42.1 24 43.6   52 46.0
***Hosmer-Lemeshow 2 22.2   2 22.2 14 48.3     9 31.4
R2 or pseudo R2 4   7.7   8 15.4   8 15.4   20 38.5
Other 5   9.6   2   3.8 13 25.0   20 38.5
19. Akaike, BIC, LR test or related performance tests 0   0   0   0   2   3.6     2   1.77
20. Discussed statistical models 4 20   7 18.4   7 12.73   18 15.9
* Including online ahead-of-print publications for 2016 and 2017 issues; ** For this table, the unit of analysis is the regression model; *** This item only 
applies to studies that used logistic regression: periods 2000-2005 (n=7), 2006-2011 (n=8), 2012-2017(n=14), and n=29 for the total of periods.
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According to Publindex, Biomédica is currently the 
journal that has the highest impact on biomedi-
cine, public health, and epidemiology in Colombia 
(6). And while Colombian research groups have 
published an increasing number of studies in 
international journals, Biomédica continues to be 
the preferred journal for publishing the results of 
research projects with national and regional impact, 
and its visibility has increased over recent decades 
(10).Therefore, Biomédica provides an appropriate 
framework to analyze the quality of statistical 
reporting in Colombia.
Previous reports have found weaknesses in the 
training in statistical competencies offered by 
postgraduate epidemiological and public health 
programs in Colombia (11). To some extent, the 
weakness in statistical skills at the postgraduate 
level might be related to the misuse and simplifi-
cation of statistical methods, including generalized 
linear regression methods (12). This review used 
the available guidelines on good practice for statis-
tical reporting to describe reports of regression 
methods that have appeared in Biomédica over 
the last 17 years since these are the most common 
statistical methods used in observational studies. 
The results of this review show that most of the 
included studies did not meet the standards of the 
guidelines and the checklist used herein to assess 
the quality of the reporting of statistical regression 
modeling methods.
Good practice guidelines for statistical reporting 
have been established mainly by expert consensus 
in order to provide guidance on how to improve 
the quality of reporting on statistical methods (5). 
However, these guidelines should not be assumed 
as a simplification of statistical methods or used 
as “recipes” to conduct statistical analyses. Strictly 
following the guidelines does not guarantee high 
quality regression analyses. Assessments of the 
quality of statistical analyses should be compre-
hensive, based on statistical rationale, and meet 
the statistical standards discussed above. 
Most of the original articles included in this review 
are observational studies which used regression 
models to control for confounders (13). The results 
of the analysis of “pre-statistical model consider-
ations”, or stage I, showed an increase over time in 
the use of combined methods to select regression 
model variables for studies of association. Never-
theless, statistical criteria based exclusively on 
hypothesis testing methods continue to be used. 
That type of statistical criteria, as well as stepwise 
methods, have been strongly criticized in recent 
decades (4,14) and modern epidemiology widely 
recognizes that model variables should be selected 
according to a more comprehensive analytical 
process, based on theoretical and literature reviews 
and using multidimensional criteria (15).
In statistics, a “misspecification error” refers to the 
use of incorrect procedures to build a regression 
model (16). The misspecification of a regression 
model could have an impact on the estimators 
obtained, thereby causing bias. The importance 
of this type of error has been well acknowledged 
(17,18) and may bias the study results. It includes 
omitting influential or including non-influential 
explanatory variables, using incorrect functional 
forms, violating the assumptions of the model, and 
using incorrect approaches to choose the final 
model (19). In this regard, it is important to note that 
most of the articles reviewed herein were weak in 
their reporting of the verification of model assump-
tions, which are key criteria for the statistical validity 
of the models.
Critical assessment reviews are significantly limited 
in their ability to distinguish between the absence of 
analysis versus a lack of reporting since quality is 
judged exclusively based on published documents. 
However, even when statistical methods are used, 
not reporting on them in itself weakens an original 
article in terms of demonstrating the validity of its 
methods and results. In the case of Biomédica, 
there are no constraints on the complete reporting 
of statistical methods since there is no word limit 
for original articles.
One important limitation of the present review 
is the use of the new checklist. Although two 
experts in statistical analyses reviewed it, it has 
not been widely reviewed by the scientific statistics 
community and, therefore, it can not be considered 
a validated instrument. In addition, since the check-
list assigned equal weight to all items, it does not 
take into account that some of the elements used 
to judge the quality of reporting may be more 
important than others. On the other hand, its 
strength is that it is a comprehensive list based on 
previous guidelines and checklists that have been 
specifically used to assess the quality of reporting 
on statistical regression modeling analyses.
In conclusion, this critical assessment review of 
original articles published over the last 17 years in a 
top biomedical journal in Colombia shows that there 
are important limitations in the quality of reporting 
on statistical regression models. An improvement 
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over time in the use of multidimensional statistical 
procedures for the selection of model variables was 
evident. However, there was a lack of reporting 
on important statistical information related to the 
four stages of analysis, thereby creating uncer-
tainty about the validity of the statistical models, 
which in turn calls into question study results 
and conclusions.
Finally, we invite researchers, reviewers, and edi-
tors of biomedical journals in Colombia to use the 
results of this critical assessment review to develop, 
promote, and control an appropriate culture for 
statistical analysis and reporting. Attaining this 
goal through the use of good practice guidelines 
for statistical reporting will lead to a more rational 
and efficient use of statistical methods, higher confi-
dence and transparency in the peer-review process, 
and overall, higher quality biomedical, public health, 
and epidemiological studies in Colombia. 
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Appendix 1. Checklist of the dimensions and/or statistical procedures reported
Stage I “Pre-statistical modelling considerations”
1. Have the objectives of the analysis been stated?
2. What is the type of regression analysis?
3. Is the sample size reported for every model presented?
4. Are there sufficient explanations of all variables?
5. What is the measurement scale of the response variable?
6. Is the transformation of variables presented or reported?
7. Is there any mention of the process for selecting the variables included in the final model presented? If so, what was this process?
7. 1. Does the paper mentionany statistical strategy for variable selection?
7.1.1 Does the paper use astepwise method? If so,forward or backward?
7. 1.2 Does the paper mention any alpha criteria for including variables?
8. Has the quality of data (missing values, outliers, possible bias, etc.) been described?
9. Was the statistical package or program used in the analysis identified?
Stage II “Specification of the final model”
10. Have any modeling assumptions been stated?
10.1 Which assumptions were verified?
11. Was colinearity evaluated?
12. Does the paper mention the strategy for assessing assumptions?
13. Did the study compare models? If so, how?
14. Does the paper report the regression equation?
Stage III. “Presentation of the final model”
15. Are the results reported graphically and/or in tables?
16. Are the regression coefficients (beta) reported for each explanatory variable? Are the corresponding confidence intervals and/
or p-values presented?
Stage IV “Validation of the final model”
17. Does the paper conduct a goodness of fit analysis?
18. Are the tests of goodness of fit mentioned?
19. Does the analysis include a test of the model’s performance?
20. Are the statistical analyses discussed?
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Appendix 2. Comparison of guidelines/checklists for presenting statistical regression analyses from the literature reviewed for the comprehensive checklist used by this analysis 
Guidelines for the presentation of statistics in 
an investigation
(Bailar, et al., 1979)
Strategies for the 
development of statistical 
regression models
(Nuñez, et al., 2011)
Proposed checklist for statistical regression analyses 
(Kearns, et al., 2013) 
General principles for reporting 
regression analyses 
(Lang, et al., 2013)
1. Describe the statistical methods in 
sufficient detail so that the reader versed in 
the subject and having access to the original 
data can verify the reported results 
 (items 2-7).
2. Whenever possible, quantify results and 
present them with appropriate indicators 
of measurement error or uncertainty                      
(e.g., confidence intervals) (item 16). 
3. Do not rely solely on proofs and statistical 
hypotheses, such as p-values, which do not 
convey important quantitative information 
(item 16).
4. Analyze the eligibility of experimental 
subjects.
5. Provide details of the randomization process.
6. Describe the means used to mask the 
observations indicate the results they gave.
7. Report on treatment complications.
8. Specify the number of observations (item 3).
9. Mention loss of subjects and observation 
(e.g., people leaving a clinical trial). (item 8)
10. Whenever possible, references to study 
design will be current, rather than original 
articles, which were described for the                
first time.
11. Specify any general purpose computer 
program used. (item 9)
12. The general descriptions of the methods used 
should appear in the Methods section. When 
summarizing the data in the Results section, 
specify the statistical methods that were used.
13. Limit the number of tables and figures 
to the minimum necessary to explain the 
central theme of the article and to evaluate the 
data on which it is based. Use graphs instead 
of tables subdivided into many parts; Do not 
duplicate data in graphs and tables (item 15) 
14. Avoid non-technical use of statistics terms
15. Define the terms, abbreviations and most of 
the statistical symbols
1. Objective, Structure 
of the data and type 
of regression analysis 
(items 1 and 2)
2. Manipulation of the data 
 (items 6- 8)
3. Strategies for modeling.
 - Automatic selection of 
variables (item 7)
4. Evaluation of the final 
model (items 17-19)
5. Presentation of results 
 (item 15-16)
Pre-modeling considerations
1. Have the objectives of the analysis been stated? (item 1)
2. Has the need for a de novo regression analysis 
 been justified?
3. Has the source of the data used been stated? 
4. Has the total sample size available been reported? (item 3)
5. Are sufficient explanations of all variables used provided? 
(item 4)
6. Are sufficient numerical and/or graphical summaries 
provided? (item 15)
7. Has the quality of data (missing values, outliers, 
 possible bias, etc.) been described? (item 8)
8. Has the type/method of regression model(s) considered 
 been stated/justified? (item 19)
9. Have any modelling assumptions been stated? (item 10)
10. Is a convincing rationale given for the inclusion of 
 explanatory variables? (item 4)
Arriving at the Final Model
11. Are sufficient details about the computational methods 
 used provided?
12. If more than one model was considered, has justification 
 been given for why the preferred model has been 
selected? (item 13)
13. Has the choice of covariates been justified? (item 4)
14. Is the sample size reported for every model presented? 
 (item 3)
15. Has the handling of missing values (if any) been described? 
Presentation of the Final Model
16. Are the coefficient estimates provided? (item 16)
17. Are appropriate measures of uncertainty and significance 
provided? (item 6) 
Validating the Final Model
18. Are summary measures of goodness of fit presented? 
 (item 17-18)
19. Are details of the results of a residual analysis provided? 
     (item 12)
20. Has the model been validated on external 
 (or quasi-external) data?
21. Is the plausibility of the modeled predictions and/or 
coefficients discussed? (item 20)
22. Are the results compared to the literature and/or other 
data? (item 13)
23. Has the method for handling parameter uncertainty 
 been reported?
24. Is sufficient detail given for how parameter uncertainty was 
handled (e.g. if a variance/covariance matrix is used, is this 
available in some form?)
25. Is parameter uncertainty appropriately reflected in the DAM?
26. Has any structural (model) uncertainty been explored 
 (in the DAM)?
27. Have the model’s limitations been discussed 
 (and explored if possible)? (item 20)
• Describe the purpose of the analysis 
 (item 1)
• Identify the variables used in the analysis 
and summarize each with descriptive 
statistics (items 5 and 6)
• Confirm that the assumptions of the 
analysis were met (item 10)
• If relevant, report how any outlying values 
were treated in the analysis. (item 8)
• Report how any missing data were treated 
in the analyses. 
• For either simple or multiple (multivariable) 
regression analyses, report the regression 
equation. (item 14)
• For multiple regression analyses: 1) 
report the alpha level used in the univariate 
analysis; (item 16) 2) report whether the 
variables were assessed for a) colinearity 
and (item 11) b) interaction; and 3) describe 
the variable selection process by which the 
final model was developed (e.g., forward-
stepwise; best subset). (item 7)
• Report the regression coefficients (beta 
weights) of each explanatory variable and 
the associated confidence intervals and 
P values, preferably in a table. (item 16) 
• Provide a measure of the model’s 
“goodness-of-fit” to the data (the 
coefficient of determination, r 2, for simple 
regression and the coefficient of multiple 
determination, R 2, for multiple regression).
(items 17- 18)
• Specify whether and how the model was 
validated. (items 18-19)
• For primary comparisons analyzed with 
simple linear regression analysis, consider 
reporting the results graphically, in a 
scatter plot showing the regression line and 
its confidence bounds. (item 15)
• Name the statistical package or program 
used in the analysis. (item 9)
*The items in bold in each guideline/checklist were the ones related specifically to the regression models used to generate this paper’s checklist. For these items, the item number corresponding to this 
paper’s checklist is indicated in parentheses and italics. The gray items were not included in this paper’s checklist as they were general guidelines related to the study design and not specifically related to the 
presentation of regression models. Some items were excluded because they were related to terminology (Nuñez’ item 2) or advanced statistical methods (Nuñez’ item 3) used in economics but not commonly 
used in public health or biomedicine. The items excluded from the Lang and Altman’s principles corresponded to a detailed explanation of the treatment of missing values, an aspect that was already included 
in this paper’s checklist as a presence/absence item.
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